Clinical, biological, and compounded approaches for severe dry eye and corneal damage refractory to conventional care.
When ocular surface diseases (such as severe dry eye, neurotrophic keratitis, or chronic epithelial defects) do not respond to commercial tear substitutes, the Ophthalmologist may evaluate advanced ophthalmic therapies. These solutions, often formulated as custom compounded medications or biological blood-derived drops, aim not merely to lubricate, but to modulate chronic inflammation and stimulate tissue regeneration.
How advanced preparations selectively target the distinct layers of the ocular surface.
Many of these active principles are not available as pre-packaged commercial drugs. They must be specifically prepared as sterile compounded medications by an authorized Compounding Pharmacist, based on a strict medical prescription. This allows for customized clinical dosages, the elimination of irritating preservatives, and access to innovative off-label molecules.
Hub informativo clinico sulle terapie galeniche e biologiche per occhio secco severo e difetti corneali: ciclosporina topica, collirio in autosiero, insulina galenica oftalmica e losartan per la prevenzione dell'haze.